JPRN-UMIN000000561已完成未知
Supplemental Benefit of Angiotensin II Receptor Blocker in Hypertensive Patients with Stable Heart Failure using Olmesartan - SUPPORT Trial
Tohoku Heart Failure Association The SUPPORT Study Group0 个研究点目标入组 1,000 人开始时间: 2006年12月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who have renal dysfunction (serum creatinine >=3.0mg/dL) or those who are receiving chronic hemodialysis. 2)History of drug hypersensitivity to olmesartan. 3)Patients who have severe liver dysfunction. 4)History of angioedema. 5)History of malignant tumor or life-threatening illness of poor prognosis. 6)Pregnant or possibly pregnant patients. 7)Cardiovascular surgery within 6months prior to the date of the entry. 8)Acute myocardial infarction within 6 months prior to the date of the entry. 9)Percutaneous coronary intervention or stent implantation within 6 months prior to the date of the entry. 10)Other patients deemed unsuitable as subjects of the study by the treating physician.
研究者
相似试验
已完成
4 期
Therapeutic Efficacy of an Angiotensin II Receptor Antagonist in Patients with Nonalcoholic Steathepatitisonalcoholic steatohepatitisJPRN-C000000202Gunma Liver Study Group10
已完成
不适用
Evaluation of the effect of AngiotensinII receptor blocker on coronary artery after Sirolimus-Eluting Stent implantatioJPRN-UMIN000001822Toyohashi Heart Ceter, Cardiovascular Medicine50
尚未招募
不适用
The Safety and Efficacy of Angiotensin II Receptor Blockers (ARBs) in Diabetic Patients with Advanced Chronic Kidney DiseaseDiabetic patients with advanced chronic kidney disease (CKD) who have newly received ARBschronic kidney disease, diabetes mellitus, angiotensin II receptor blockers, renin-angiotensin system inhibitorsTCTR20210526006Division of Nephrology, Department of Internal Medicine, Thammasat University Hospital165
已完成
不适用
The effect of angiotensin II receptor blocker (ARB) or thiazolidinedione (TZD) on adipocytokines and oxidative stress markers (Senri Study II)Hypertensive and/or Diabetic patientsJPRN-UMIN000001456Department of Metabolic Medicine, Graduate School of Medicine, Osaka University200
已完成
不适用
Impact of angiotensin II receptor antagoniston on adriamycin-induced cardiomyopathyMarignancy patients who will treat with adriamycinJPRN-UMIN000005066Division of Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine100